DrugPatentWatch Database Preview
Drugs in Development Information for Nitrendipine
Development status for investigational drug Nitrendipine: Sponsors, patents, clinical trial progress
Nitrendipine is an investigational drug.
There have been 6 clinical trials for Nitrendipine.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2009.
The most common disease conditions in clinical trials are Hypertension, Renal Insufficiency, Chronic, and Kidney Diseases. The leading clinical trial sponsors are Merck KGaA, University of Erlangen-Nürnberg Medical School, and Daiichi Sankyo Europe, GmbH.
There are two US patents protecting this investigational drug and eighteen international patents.
Summary for Nitrendipine
| US Patents | 2,107 |
| International Patents | 18,093 |
| US Patent Applications | 3,426 |
| WIPO Patent Applications | 2,132 |
| Japanese Patent Applications | 12 |
| Clinical Trial Progress | Phase 3 (2009-11-01) |
| Vendors | 76 |
Recent Clinical Trials for Nitrendipine
| Title | Sponsor | Phase |
|---|---|---|
| Clinical Studies by Using Accelerated PDX Model to Screen Drugs for Advanced Solid Tumor | Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
| Treatment of Hypertension in Tibetan Adult Population | West China Hospital | Phase 4 |
| Sympathetic Nerve Activity in Renal Failure | University of Erlangen-Nürnberg Medical School | Phase 4 |
Clinical Trial Summary for Nitrendipine
Top disease conditions for Nitrendipine
Top clinical trial sponsors for Nitrendipine
US Patents for Nitrendipine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Nitrendipine | Start Trial | Methods and compositions for treating infection | UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS) | Start Trial |
| Nitrendipine | Start Trial | Therapeutic approaches for treating Parkinson's disease | Pharnext (Issy les Moulineaux, FR) | Start Trial |
| Nitrendipine | Start Trial | Combination therapy | Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) | Start Trial |
| Nitrendipine | Start Trial | Neprilysin inhibitors | THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) | Start Trial |
| Nitrendipine | Start Trial | Synthetic linear apelin mimetics for the treatment of heart failure | NOVARTIS AG (Basel, CH) | Start Trial |
| Nitrendipine | Start Trial | Combining electronic monitoring with inhaled pharmacological therapy to manage cardiac arrhythmias including atrial fibrillation | INCARDA THERAPEUTICS, INC. (Newark, CA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Nitrendipine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Nitrendipine | World Intellectual Property Organization (WIPO) | 2014052836 | 2032-09-27 | Start Trial |
| Nitrendipine | Australia | 2012222348 | 2031-03-01 | Start Trial |
| Nitrendipine | Australia | 2012222351 | 2031-03-01 | Start Trial |
| Nitrendipine | Australia | 2013224959 | 2031-03-01 | Start Trial |
| Nitrendipine | Australia | 2013224960 | 2031-03-01 | Start Trial |
| Nitrendipine | Australia | 2014314055 | 2031-03-01 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
